TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25101536

Group type: EXPERIMENTAL
Intervention: 160 W Greenlight laser vaporization of the prostate
Number of subjects: 80

Group type: COMPARATOR
Intervention: 80 W Greenlight laser vaporization of the prostate
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (160 W and 80 W)
Number of subjects: 80
Study: 22791671

Group type: EXPERIMENTAL
Intervention: Ringers lactate (RL)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 22
Study: 20531101

Group type: EXPERIMENTAL
Intervention: Violence prevention program based on Latino cultural values
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18726689

Group type: EXPERIMENTAL
Intervention: Reduction in tooth contact via habit reversal techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parafunctional activities
Number of subjects: 0
Study: 15994626

Group type: EXPERIMENTAL
Intervention: Sexually active women (39% of participants)
Number of subjects: 2763

Group type: EXPERIMENTAL
Intervention: Factors associated with sexual activity
Number of subjects: 2763

Group type: EXPERIMENTAL
Intervention: Sexually active women (1,091 participants)
Number of subjects: 2763
Study: 12842988

Group type: EXPERIMENTAL
Intervention: Lower expression levels of fusion transcripts at diagnosis
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: New prognostic score based on median expression ratio after consolidation therapy and 75th percentile of expression ratio at diagnosis
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: High levels of fusion gene expression at diagnosis or less than 3 logs of tumor reduction during the first 3 to 4 months of therapy
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Increasing levels of expression during follow-up
Number of subjects: 349
Study: 11053067

Group type: EXPERIMENTAL
Intervention: 12 week exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aging
Number of subjects: 30
Study: 8741364

Group type: EXPERIMENTAL
Intervention: 2 mg/day estriol for 10 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: 1 g/day calcium lactate for 10 months (control)
Number of subjects: 49
Study: 1430999

Group type: EXPERIMENTAL
Intervention: Monotherapy with a cephalosporin (broad-spectrum agent)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Combination therapy (beta-lactam and aminoglycoside)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Monotherapy with a cephalosporin
Number of subjects: 231
Study: 4008809

Group type: EXPERIMENTAL
Intervention: Hydroxyzine, 50 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine, 16 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Promethazine, 50 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tripelennamine, 100 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diphenhydramine, 50 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cyproheptadine, 16 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hydroxyzine, 75 mg per day for 3 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine, 24 mg per day for 3 weeks
Number of subjects: 18
Study: 31403793

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) for Volume of Distribution at Steady State (VDss)
Number of subjects: 1352

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) for Clearance (CL)
Number of subjects: 1352

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) for Terminal Half‐Life (t1/2)
Number of subjects: 1352

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) for Fraction Unbound in Plasma (fu)
Number of subjects: 1352
Study: 29466591

Group type: EXPERIMENTAL
Intervention: 2 mg haloperidol
Number of subjects: 1789

Group type: EXPERIMENTAL
Intervention: 1 mg haloperidol
Number of subjects: 1789

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride)
Number of subjects: 1789
Study: 26297029

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Resistance Training + Caloric Restriction (RT+CR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: RT+CR
Number of subjects: 32
Study: 24345204

Group type: EXPERIMENTAL
Intervention: Self-ligating brackets with elastomeric ligature
Number of subjects: 24

Group type: COMPARATOR
Intervention: Self-ligating brackets without elastomeric ligature
Number of subjects: 24

Group type: COMPARATOR
Intervention: Molar bands and bonded molar tubes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Molar bonds
Number of subjects: 24
Study: 22834284

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with 0.75% ropivacaine and sevorane-propofol general anaesthesia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Infusion of 0.2% ropivacaine with fentanyl (1 microg/ml) and epinephrine (2 microg/ml) via 2 epidural catheters
Number of subjects: 150

Group type: COMPARATOR
Intervention: Propofol-fentanyl TIVA or inhalational sevorane-fentanyl
Number of subjects: 150
Study: 20605555

Group type: EXPERIMENTAL
Intervention: Ischemic compression therapy on shoulder trigger points (supraspinatus, infraspinatus, deltoid, biceps tendon)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Ischemic compression therapy on cervical and upper thoracic areas (control group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ischemic compression therapy on shoulder trigger points (after crossover for control group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ischemic compression therapy on shoulder trigger points
Number of subjects: 41
Study: 18060612

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 952

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 952
Study: 16170946

Group type: EXPERIMENTAL
Intervention: Overtaking maneuvers in a driving simulator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Closing speed adaptation
Number of subjects: 0
Study: 12483184

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy with streptokinase (250,000 units bolus followed by 100,000 units/hr, max 4,000,000 units)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Heparin (anticoagulation)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy with streptokinase
Number of subjects: 97
Study: 9891197

Group type: EXPERIMENTAL
Intervention: RW94 (5 grams administered orally after each main meal)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (maize starch)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: RW94
Number of subjects: 32
Study: 8193507

Group type: EXPERIMENTAL
Intervention: Hypoallergenic diet (soy milk or hydrolyzed milk formulas for non-breast-fed; diet without cow's milk, eggs or fish for breast-fed)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dicyclomine hydrochloride 3 mg/kg/day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Soy milk and hydrolyzed milk formulas
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pharmacological treatment (dicyclomine)
Number of subjects: 120
Study: 2454355

Group type: EXPERIMENTAL
Intervention: 5 or 10 mg carvedilol once daily for 3 to 7 days, increased to 20 mg daily if BP reduction was insufficient
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo for 1 week
Number of subjects: 31
Study: 28836339

Group type: EXPERIMENTAL
Intervention: Visual estimation
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Single‐vessel QCA
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 2D bifurcation QCA
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 3D bifurcation QCA
Number of subjects: 113
Study: 27875516

Group type: EXPERIMENTAL
Intervention: 12 months of trastuzumab treatment
Number of subjects: 2500

Group type: COMPARATOR
Intervention: 6 months of trastuzumab treatment
Number of subjects: 2500
Study: 24881311

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol succinate sustained release
Number of subjects: 0
Study: 23987719

Group type: EXPERIMENTAL
Intervention: Urodynamic traces assessed for adherence to BUS standard operating procedure
Number of subjects: 64
Study: 21574781

Group type: EXPERIMENTAL
Intervention: Trained (T)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untrained (UT)
Number of subjects: 60
Study: 19881003

Group type: EXPERIMENTAL
Intervention: Abdominal drawing-in maneuver (ADIM)
Number of subjects: 30
Study: 16214284

Group type: EXPERIMENTAL
Intervention: One‐Step Plus with total‐etch technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: One‐Step Plus with self‐etch technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: One‐Step with total‐etch technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: One‐Step with self‐etch technique
Number of subjects: 20
Study: 15238368

Group type: EXPERIMENTAL
Intervention: Hospitalist model of care
Number of subjects: 526

Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 526
Study: 11339980

Group type: EXPERIMENTAL
Intervention: SAS macro for sample size re-estimation using EM algorithm
Number of subjects: 0
Study: 9246699

Group type: EXPERIMENTAL
Intervention: 10 mg omeprazole once daily
Number of subjects: 495

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 495
Study: 8334339

Group type: EXPERIMENTAL
Intervention: Baoshen Pill (Rheum palmatum extract, RPE)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 6430311

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 80

Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Althesin
Number of subjects: 80
Study: 30530959

Group type: EXPERIMENTAL
Intervention: Kinesio Tape (KT) - Upper trunk group (UTG)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Kinesio Tape (KT) - Global trunk group (GTG)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Kinesio Tape (KT) - Both groups
Number of subjects: 35
Study: 30129815

Group type: EXPERIMENTAL
Intervention: 60 grams/day of freeze-dried grape powder (GRAPE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 26677207

Group type: EXPERIMENTAL
Intervention: PA resource kit consisting of tailored print materials and a step pedometer
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard public health PA recommendation
Number of subjects: 95
Study: 24022919

Group type: EXPERIMENTAL
Intervention: Water aerobic training (n = 19)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dry land aerobic training (n = 19)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-intervention control group (n = 14)
Number of subjects: 52
Study: 23035867

Group type: EXPERIMENTAL
Intervention: High post-randomization mean IOP level and/or large variability in IOP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline factors including treatment assignment, baseline IOP, gender, race, and history of hypertension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different patterns of IOP change identified in EGPS
Number of subjects: 0
Study: 20588018

Group type: EXPERIMENTAL
Intervention: Postconditioning (ischemic postconditioning with short repetitive cycles of reperfusion and re-occlusion)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Postconditioning
Number of subjects: 260
Study: 17446206

Group type: EXPERIMENTAL
Intervention: 60 mg atomoxetine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 30 mg citalopram
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 16463414

Group type: EXPERIMENTAL
Intervention: Deep Water Running (DWR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Land-Based Exercises (LBE)
Number of subjects: 60
Study: 15645907

Group type: EXPERIMENTAL
Intervention: Dual-phase fluoride dentifrice containing sodium bicarbonate, calcium, and phosphate
Number of subjects: 87

Group type: COMPARATOR
Intervention: Regular fluoride dentifrice (control)
Number of subjects: 87
Study: 10758456

Group type: EXPERIMENTAL
Intervention: Proximal cranial needle approach for brachial plexus blockade
Number of subjects: 0
Study: 8751804

Group type: EXPERIMENTAL
Intervention: Oral 5-FU (Group A)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Oral Tegafur (Group B)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: i.v. MMC + oral 5-FU (Group C)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Stage II (Group A)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Stage II (Group B)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Stage II (Group C)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Stage III (Group A)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Stage III (Group B)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Stage III (Group C)
Number of subjects: 874
Study: 1290861

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (bolus-fed)
Number of subjects: 21
Study: 6691531

Group type: EXPERIMENTAL
Intervention: Patient outcome measurement instruments
Number of subjects: 48
Study: 30654249

Group type: EXPERIMENTAL
Intervention: High plasma selenium concentration
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: High plasma selenium concentration and high DMA%
Number of subjects: 266
Study: 28276001

Group type: EXPERIMENTAL
Intervention: Amino-acid-based formula
Number of subjects: 153

Group type: COMPARATOR
Intervention: Soy-protein-based formula
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Amino-acid-based formula and Soy-protein-based formula
Number of subjects: 153
Study: 26232831

Group type: EXPERIMENTAL
Intervention: Audiovisual information via YouTube (6-minute video)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine verbal and written patient information
Number of subjects: 60
Study: 23914462

Group type: EXPERIMENTAL
Intervention: Segmented podcast lecture
Number of subjects: 35

Group type: COMPARATOR
Intervention: Unsegmented podcast lecture
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional face-to-face lecture
Number of subjects: 35
Study: 22224244

Group type: EXPERIMENTAL
Intervention: Ceraxon (2 g daily for 10 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Cerebrolysin (10 ml daily for 10 days)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (basic treatment without neuroprotectors)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 106
Study: 18976988

Group type: EXPERIMENTAL
Intervention: Statistical decision-making based on hidden state inference
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prediction of future outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Particle filter model
Number of subjects: 0
Study: 16525816

Group type: EXPERIMENTAL
Intervention: 5 mg sarizotan HCl b.i.d. for 8 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12740037

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 45
Study: 10740549

Group type: COMPARATOR
Intervention: Fentanyl 0 micrograms kg-1
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms kg-1
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Fentanyl 4 micrograms kg-1
Number of subjects: 61
Study: 8737134

Group type: EXPERIMENTAL
Intervention: Sparfloxacin (400 mg loading dose on day 1 followed by 200 mg once daily for pneumonia; 200 mg loading dose on day 1 followed by 100 mg daily for COPD)
Number of subjects: 2081

Group type: COMPARATOR
Intervention: Comparator regimens (amoxycillin/clavulanic acid 500/125 mg tid, amoxycillin 1000 mg tid, amoxycillin 1000 mg tid plus ofloxacin 200 mg bid, erythromycin 1000 mg bid)
Number of subjects: 2081
Study: 1577399

Group type: EXPERIMENTAL
Intervention: Etomoxir 50 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6374921

Group type: EXPERIMENTAL
Intervention: Chymopapain (Chymopapain group 1)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Chymopapain (Chymopapain group 2)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Surgery (Surgical group)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Chymopapain (failed Chymopapain group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Surgery (failed Chymopapain group)
Number of subjects: 52
Study: 30739019

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel/carboplatin (nab-PC)
Number of subjects: 127

Group type: COMPARATOR
Intervention: gemcitabine/carboplatin (GC)
Number of subjects: 127
Study: 30051934

Group type: EXPERIMENTAL
Intervention: Kindness intervention
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Gratitude intervention
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control condition (treatment as usual)
Number of subjects: 144
Study: 27665153

Group type: EXPERIMENTAL
Intervention: Provider's LARC training intervention
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 1500
Study: 24522288

Group type: EXPERIMENTAL
Intervention: 1,000 lx of fluorescent lighting environment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Dark environment
Number of subjects: 17
Study: 22314458

Group type: EXPERIMENTAL
Intervention: Pre-bypass methylprednisolone 30mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Post-bypass methylprednisolone 30mg/kg
Number of subjects: 40
Study: 20561314

Group type: EXPERIMENTAL
Intervention: Caries Management System
Number of subjects: 0
Study: 17587394

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 16259890

Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable gastric banding (LAGB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open vertical banded gastroplasty (VBG)
Number of subjects: 100
Study: 11792161

Group type: EXPERIMENTAL
Intervention: Acute treatment with levetiracetam (500 mg twice daily)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Chronic treatment with levetiracetam (individualized, 500-1000 mg twice daily for 8 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 10
Study: 9504515

Group type: EXPERIMENTAL
Intervention: Atovaquone plus proguanil
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study: 8295772

Group type: EXPERIMENTAL
Intervention: Dipyridamole (0.56 mg/kg/4 min or 0.84 mg/kg over 10 min)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Dobutamine (10-20-30-40 micrograms/kg/min over 3 min each step)
Number of subjects: 41
Study: 3057962

Group type: EXPERIMENTAL
Intervention: Antihistamine-decongestant therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31231780

Group type: EXPERIMENTAL
Intervention: 2 doses at months 0 and 6
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: 3 doses at months 0, 1 and 6
Number of subjects: 301

Group type: COMPARATOR
Intervention: 3 doses in women aged 18-26 years
Number of subjects: 301
Study: 31083194

Group type: EXPERIMENTAL
Intervention: 75IU HMG and 75IU rFSH
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 150IU rFSH and 75IU rLH
Number of subjects: 3

Group type: COMPARATOR
Intervention: 150IU rFSH alone
Number of subjects: 3
Study: 28695267

Group type: EXPERIMENTAL
Intervention: AAFP 500 mg with methylprednisolone (4 mg twice daily)
Number of subjects: 37

Group type: COMPARATOR
Intervention: OAA 1000 mg with prednisone (5 mg twice daily)
Number of subjects: 37
Study: 23299569

Group type: EXPERIMENTAL
Intervention: Systematic screening early identification (SS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Consultation‐based early identification (CEI)
Number of subjects: 0
Study: 21639872

Group type: EXPERIMENTAL
Intervention: Autologous E.coli autovaccine
Number of subjects: 9
Study: 18419441

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg/day)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Doxycycline alone
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Doxycycline plus diethylcarbamazine-albendazole
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo doxycycline plus diethylcarbamazine-albendazole
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Doxycycline plus placebo diethylcarbamazine-albendazole
Number of subjects: 161
Study: 16497347

Group type: EXPERIMENTAL
Intervention: Chloroquine (3-day regimen)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Quinine (3-day regimen)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Chloroquine plus Primaquine
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Quinine plus Primaquine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Chloroquine and Quinine
Number of subjects: 62
Study: 12831736

Group type: EXPERIMENTAL
Intervention: Increased knee flexion velocity at toe-off to normal levels
Number of subjects: 32

Group type: COMPARATOR
Intervention: Average knee extension moment from toe-off to peak flexion
Number of subjects: 32

Group type: COMPARATOR
Intervention: Knee flexion velocity at toe-off
Number of subjects: 32
Study: 11122544

Group type: EXPERIMENTAL
Intervention: Enoxaparin alone
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Enoxaparin plus tirofiban
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: UFH plus tirofiban
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo for enoxaparin
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo for tirofiban
Number of subjects: 900
Study: 9154031

Group type: EXPERIMENTAL
Intervention: Management by trainee doctors with indirect assistance from computerised decision support system
Number of subjects: 148

Group type: COMPARATOR
Intervention: Management by trainee doctors without assistance from computerised decision support system
Number of subjects: 148
Study: 7634283

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment to achieve blood pressure levels below 85 mmHg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 2454357

Group type: EXPERIMENTAL
Intervention: Carvedilol 50 mg, administered orally, single and twice daily regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol (control)
Number of subjects: 0